Related references
Note: Only part of the references are listed.Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia
Mohini Rajasagi et al.
BLOOD (2014)
Surveillance of the Tumor Mutanome by T Cells during Progression from Primary to Recurrent Ovarian Cancer
Darin A. Wick et al.
CLINICAL CANCER RESEARCH (2014)
Efficient Identification of Mutated Cancer Antigens Recognized by T Cells Associated with Durable Tumor Regressions
Yong-Chen Lu et al.
CLINICAL CANCER RESEARCH (2014)
Genetic manipulation of B cells for the isolation of rare therapeutic antibodies from the human repertoire
Mark J. Kwakkenbos et al.
METHODS (2014)
Cancer Immunotherapy Based on Mutation-Specific CD4+T Cells in a Patient with Epithelial Cancer
Eric Tran et al.
SCIENCE (2014)
Anti-CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response
Pia Kvistborg et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Exomics and immunogenics Bridging mutational load and immune checkpoints efficacy
Stephane Champiat et al.
ONCOIMMUNOLOGY (2014)
Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma
Nienke van Rooij et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Mutated PPP1R3B Is Recognized by T Cells Used To Treat a Melanoma Patient Who Experienced a Durable Complete Tumor Regression
Yong-Chen Lu et al.
JOURNAL OF IMMUNOLOGY (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
The regulatory landscape for actively personalized cancer immunotherapies
Cedrik M. Britten et al.
NATURE BIOTECHNOLOGY (2013)
Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
Paul F. Robbins et al.
NATURE MEDICINE (2013)
MiTCR: software for T-cell receptor sequencing data analysis
Dmitriy A. Bolotin et al.
NATURE METHODS (2013)
Enhancement of Tumor-Reactive Cytotoxic CD4+ T-cell Responses after Ipilimumab Treatment in Four Advanced Melanoma Patients
Shigehisa Kitano et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Mining the mutanome: developing highly personalized Immunotherapies based on mutational analysis of tumors
Willem W. Overwijk et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2013)
Tumor-specific CD4+ Melanoma Tumor-infiltrating Lymphocytes
Kevin M. Friedman et al.
JOURNAL OF IMMUNOTHERAPY (2012)
TIL therapy broadens the tumor-reactive CD8+ T cell compartment in melanoma patients
Pia Kvistborg et al.
ONCOIMMUNOLOGY (2012)
Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+and CD8+T cells in combination with low-dose interferon-alpha
Els M. E. Verdegaal et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
Ignacio Varela et al.
NATURE (2011)
Fast and accurate long-read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2010)
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
Sergio A. Quezada et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation
Cole Trapnell et al.
NATURE BIOTECHNOLOGY (2010)
Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming
Mark J. Kwakkenbos et al.
NATURE MEDICINE (2010)
TopHat: discovering splice junctions with RNA-Seq
Cole Trapnell et al.
BIOINFORMATICS (2009)
The Sequence Alignment/Map format and SAMtools
Heng Li et al.
BIOINFORMATICS (2009)
Fast and accurate short read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2009)
Tumor Antigen-Specific FOXP3+ CD4 T Cells Identified in Human Metastatic Melanoma: Peptide Vaccination Results in Selective Expansion of Th1-like Counterparts
Camilla Jandus et al.
CANCER RESEARCH (2009)
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia.
Gemma G. Kenter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Treatment of metastatic melanoma with autologous CD4+T cells against NY-ESO-1
Naomi N. Hunder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Tumor-specific CD4+ T cells from a patient with renal cell carcinoma recognize diverse shared antigens
J Mautner et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Constitutive expression of MHC class II genes in melanoma cell lines results from the transcription of class II transactivator abnormally initiated from its B cell-specific promoter
V Deffrennes et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
